These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16706984

  • 1. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively.
    McCarty OJ, Calaminus SD, Berndt MC, Machesky LM, Watson SP.
    J Thromb Haemost; 2006 Jun; 4(6):1367-78. PubMed ID: 16706984
    [Abstract] [Full Text] [Related]

  • 2. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
    Yuan Y, Dopheide SM, Ivanidis C, Salem HH, Jackson SP.
    J Biol Chem; 1997 Aug 29; 272(35):21847-54. PubMed ID: 9268316
    [Abstract] [Full Text] [Related]

  • 3. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
    Delaney MK, Liu J, Zheng Y, Berndt MC, Du X.
    Arterioscler Thromb Vasc Biol; 2012 Nov 29; 32(11):2761-8. PubMed ID: 22995516
    [Abstract] [Full Text] [Related]

  • 4. The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.
    Liu J, Pestina TI, Berndt MC, Steward SA, Jackson CW, Gartner TK.
    J Thromb Haemost; 2004 Dec 29; 2(12):2213-22. PubMed ID: 15613029
    [Abstract] [Full Text] [Related]

  • 5. Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an alphaIIbbeta3- and aggregation-independent manner.
    Liu J, Pestina TI, Berndt MC, Jackson CW, Gartner TK.
    Blood; 2005 Oct 15; 106(8):2750-6. PubMed ID: 15985541
    [Abstract] [Full Text] [Related]

  • 6. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK, López JA.
    Blood; 2001 Jan 01; 97(1):162-8. PubMed ID: 11133756
    [Abstract] [Full Text] [Related]

  • 7. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M, Facey DA, Favaloro EJ, Hertzberg MS, Whisstock JC, McNally T, Andrews RK, Berndt MC.
    Blood; 2000 Jan 01; 95(1):164-72. PubMed ID: 10607699
    [Abstract] [Full Text] [Related]

  • 8. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors.
    Kasirer-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, Shattil SJ.
    Blood; 2004 May 01; 103(9):3403-11. PubMed ID: 14726383
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.
    Roberts W, Michno A, Aburima A, Naseem KM.
    J Thromb Haemost; 2009 Dec 01; 7(12):2106-15. PubMed ID: 19765213
    [Abstract] [Full Text] [Related]

  • 10. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin alpha(IIb)beta(3).
    Yap CL, Anderson KE, Hughan SC, Dopheide SM, Salem HH, Jackson SP.
    Blood; 2002 Jan 01; 99(1):151-8. PubMed ID: 11756165
    [Abstract] [Full Text] [Related]

  • 11. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
    Cauwenberghs N, Ajzenberg N, Vauterin S, Hoylaerts MF, Declerck PJ, Baruch D, Deckmyn H.
    Haemostasis; 2000 Jan 01; 30(3):139-48. PubMed ID: 11014964
    [Abstract] [Full Text] [Related]

  • 12. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
    Matsui T, Hori A, Hamako J, Matsushita F, Ozeki Y, Sakurai Y, Hayakawa M, Matsumoto M, Fujimura Y.
    J Thromb Haemost; 2017 Mar 01; 15(3):538-548. PubMed ID: 28071872
    [Abstract] [Full Text] [Related]

  • 13. Extracellular signal-regulated kinase 5 associates with casein kinase II to regulate GPIb-IX-mediated platelet activation via the PTEN/PI3K/Akt pathway.
    Cheng Z, Gao W, Fan X, Chen X, Mei H, Liu J, Luo X, Hu Y.
    J Thromb Haemost; 2017 Aug 01; 15(8):1679-1688. PubMed ID: 28603902
    [Abstract] [Full Text] [Related]

  • 14. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation.
    Yin H, Stojanovic A, Hay N, Du X.
    Blood; 2008 Jan 15; 111(2):658-65. PubMed ID: 17914025
    [Abstract] [Full Text] [Related]

  • 15. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor.
    Depraetere H, Ajzenberg N, Girma JP, Lacombe C, Meyer D, Deckmyn H, Baruch D.
    Blood; 1998 May 15; 91(10):3792-9. PubMed ID: 9573016
    [Abstract] [Full Text] [Related]

  • 16. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D.
    Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906
    [Abstract] [Full Text] [Related]

  • 17. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA, Mancuso DJ, Evan Sadler J, Ponder JW, Jozwiak MA, Christopherson PA, Cox Gill J, Paul Scott J, Montgomery RR.
    Blood; 1998 Mar 01; 91(5):1572-81. PubMed ID: 9473222
    [Abstract] [Full Text] [Related]

  • 18. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
    Lei X, Reheman A, Hou Y, Zhou H, Wang Y, Marshall AH, Liang C, Dai X, Li BX, Vanhoorelbeke K, Ni H.
    Thromb Haemost; 2014 Feb 01; 111(2):279-89. PubMed ID: 24172860
    [Abstract] [Full Text] [Related]

  • 19. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E, Kristoffersson AC, Isaksson C, Holmberg L, Lethagen S.
    Eur J Haematol; 2008 Nov 01; 81(5):384-90. PubMed ID: 18637125
    [Abstract] [Full Text] [Related]

  • 20. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B, Houllier A, Meyer D, Girma JP.
    Blood; 1999 Mar 15; 93(6):1959-68. PubMed ID: 10068669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.